← Product Code [JIX](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIX) · K041870

# N APOLIPOPROTEIN STANDARD SERUM (K041870)

_Dade Behring, Inc. · JIX · Jul 27, 2004 · Clinical Chemistry · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIX/K041870

## Device Facts

- **Applicant:** Dade Behring, Inc.
- **Product Code:** [JIX](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIX.md)
- **Decision Date:** Jul 27, 2004
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 862.1150
- **Device Class:** Class 2
- **Review Panel:** Clinical Chemistry

## Indications for Use

For calibration of the Apolipoprotein A-I and Apolipoprotein B assays on BN™ Systems.

## Device Story

N Apolipoprotein Standard Serum is a lyophilized human serum-based calibrator containing stabilizers and preservatives. It is used in clinical laboratory settings to establish reference curves for the quantitative determination of Apolipoprotein A-I and Apolipoprotein B assays on BN™ Systems. The calibrator is reconstituted by laboratory personnel and used to calibrate the analytical system, ensuring accurate measurement of patient samples. This process supports clinical decision-making regarding lipid metabolism and cardiovascular risk assessment.

## Clinical Evidence

No clinical data. Performance was established via bench testing, specifically stability studies. Stability was evaluated over three lots at 2° to 8° C, demonstrating no significant change in recovery for at least 36 months (unopened) and 15 days once reconstituted.

## Technological Characteristics

Lyophilized reagent; human serum matrix; immunonephelometric assay principle; calibrated against WHO reference preparations SP1-01 and SP3-07; compatible with Dade Behring BN Systems.

## Regulatory Identification

A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)

## Special Controls

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

## Predicate Devices

- Randox Laboratories Apolipoprotein Calibrator ([K023158](/device/K023158.md))

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}

510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION
DECISION SUMMARY
DEVICE ONLY TEMPLATE

A. 510(k) Number: K041870

B. Purpose for Submission: This Premarket Notification provides information demonstrating that Dade Behring’s N Apolipoprotein Standard Serum is substantially equivalent to products that were in commercial distribution prior to May 28, 1976 or since cleared through the 510(k) process.

C. Analyte: N Apolipoprotein Standard Serum

D. Type of Test: Calibrator, immunonephelometric assay

E. Applicant: Dade Behring Inc

F. Proprietary and Established Names:
Proprietary – N Apolipoprotein Standard Serum
Established Name - lipoprotein calibrator

G. Regulatory Information:
1. Regulation section: 21 CFR 862.1150
2. Classification: Class II
3. Product Code: JIX
4. Panel: 75

H. Intended Use:
1. Intended use(s): Establishment of reference curves for the quantitative immunonephelometric determination of Apolipoprotein AI and Apolipoprotein B assays using BN Systems
2. Indication(s) for use: For Calibration of the Apolipoprotein A-I and B assays on BN Systems
3. Special condition for use statement(s): For prescription use only
4. Special instrument Requirements: This calibrator is for use on the Dade Behring BN Systems

{1}

Page 2 of 3

I. Device Description: N Apolipoprotein Standard Serum is a lyophilized reagent prepared from human serum. The concentration of the Apolipoprotein AI and B were calibrated against the IRP SP1-01 and IRP SP3-07 and are lot dependent.

J. Substantial Equivalence Information:

1. Predicate device name(s): Randox Laboratories Apolipoprotein Calibrator
2. Predicate K number(s): K023158
3. Comparison with predicate:

|  Predicate Comparisons  |   |   |
| --- | --- | --- |
|  Item | Device | Predicate  |
|  Intended Use | For the calibration of Apolipoprotein A-I and Apolipoprotein B assays Dade Behring BN Systems. | Apolipoprotein Calibrator based on the lyophilized human serum for use in the calibration of Apolipoprotein A-I and Apolipoprotein B assays. The constituent concentrations of the Randox Laboratories Limited Apolipoprotein Calibrator are present at 1 level.  |
|  Matrix | Stabilized reagent prepared from pooled human serum. | Stabilized reagent prepared from pooled human serum.  |
|  Analytes | Apolipoprotein A-I, B | Apolipoprotein A-I, B  |
|  Form | Lyophilized | Lyophilized  |

K. Standard/Guidance Document Referenced (if applicable): ODE Guidance "Deciding When to Submit a 510(k) for a Change to an Existing Device (K97-1)", dated January 10, 1997..

L. Test Principle: Immunonephelometric

M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility: n/a
b. Linearity/assay reportable range: n/a

{2}

Page 3 of 3

c. Traceability (controls, calibrators, or method): N Apolipoprotein Standard Serum is prepared from pooled human serum from selected healthy donors. N Apolipoprotein Standard Serum is calibrated against the international (WHO) reference preparation SP1-01 for Apolipoprotein A-I and SP3-07 for Apolipoprotein B. Stability was evaluated by testing N Apolipoprotein Standard Serum in duplicate at each time point for a total of three lots. The standard was evaluated at the recommended storage temperature of 2 to 8 °C. Stability testing supports no significant change in recovery for at least 36 months, and for 15 days, once reconstituted.

d. Detection limit: n/a

e. Analytical specificity: n/a

f. Assay cut-off: n/a

2. Comparison studies:

a. Method comparison with predicate device:

b. Matrix comparison: Stabilized reagent prepared from pooled human serum.

3. Clinical studies:

a. Clinical sensitivity: N/A

b. Clinical specificity: N/A

c. Other clinical supportive data (when a and b are not applicable): N/A

4. Clinical cut-off: N/A

5. Expected values/Reference range: N/A

N. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.

---

**Source:** [https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIX/K041870](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIX/K041870)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com